Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis Elimination
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the triple co administration of
albendazole, ivermectin and azithromycine is as safe as the current treatment scheme that
consists to treat with albendazole plus ivermectin together and a week later to treat with
azithromycin in areas co endemic for lymphatic filariasis and trachoma.